The QualityStocks Daily Monday, March 25th, 2019

Today's Top 3 Investment Newsletters

CryptoCurrencyWire (PFSF) +175.00%

PoliticsAndMyPortfolio (TAUG) +33.04%

StockMarketWatch (AVYA) +32.55%

The QualityStocks Daily Stock List

Avita Medical Limited (AVMXY)

Hot Copper, Speculating Stocks, InvestorsHub, MarketWatch, Stockhouse, Stock Invest, Street Insider, The StreetWise Reports, Marketbeat, OTC Markets, The Street, Penny Stock Picks, Zacks, Trading View, Edison Investment Research, Marketwired, Business Insider, GuruFocus, Wallet Investor, 4-Traders and Amigo Bulls reported earlier on Avita Medical Limited (AVMXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Avita Medical Limited provides an inventive approach to skin regeneration. The Company’s products are for the treatment of a broad array of wounds, scars, and skin defects. These products are presently available directly in the United Kingdom (UK), Germany, Australia and New Zealand and worldwide through distributors in France, Belgium, the Netherlands, Turkey, China, Malaysia, Taiwan, Iran and South Africa.

A medical device company and OTCQX-listed, Avita Medical operates from offices in Wimbledon, UK; Valencia, California, and Perth, Australia. PM360, a foremost trade magazine for marketing decision makers in the pharmaceutical, biotechnology, medical device, and diagnostics industries, named Avita Medical as one of the most innovative companies of 2018.

Avita Medical’s portfolio (in all countries outside of Europe) is marketed under the ReCell® brand to promote skin healing in a wide assortment of applications. These include burns, chronic wounds, and aesthetics. In the U.S, ReCell® is an investigational device limited by federal law to investigational and compassionate use.

The Company’s patented and proprietary collection and application technology provides unique treatment solutions derived from the regenerative properties of a patient’s own skin. Avita’s medical devices work by preparing a Regenerative Epithelial Suspension (RES™). This is an autologous suspension consisting of the patients’ own skin cells and wound healing factors that are essential to regenerate natural healthy skin. This is subsequently applied to the area to undergo treatment.

Avita Medical’s portfolio of medical device products received CE-mark approval in Europe as three tailored product presentations, with three individual brand names. These are ReCell®, ReGenerCell™, and ReNovaCell™. The design of ReCell® is for the treatment of burns and plastic reconstructive procedures. ReGenerCell™ has been formulated for chronic wounds. This includes leg and foot ulcers. ReNovaCell™ is tailored for aesthetic applications, which includes pigmentation restoration.

Avita Medical announced this past January that it began the U.S. national market launch of the RECELL® Autologous Cell Harvesting Device (RECELL® System) for the treatment of acute thermal burns in patients 18 years and older. The U.S. sales team of Regenerative Tissue Specialists and Clinical Training Specialists, which joined AVITA Medical in November 2018, have been trained and were fully deployed throughout the U.S. in support of the nationwide launch of the RECELL System.

Earlier this month, AVITA Medical announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL® Autologous Cell Harvesting Device (RECELL® System) for the treatment of burns and other wounds in Japan. COSMOTEC filed on February 25, 2019 a Japan’s Pharmaceuticals and Medical Devices Act (JPMDA) application for approval to market the RECELL System in Japan. The JPMDA has accepted the application. The expectation is that the review will take nine months to a year.

Avita Medical Limited (AVMXY), closed Monday's trading session at $3.87, down 3.73%, on 613,328 volume with 558 trades. The average volume for the last 3 months is 216,255 and the stock's 52-week low/high is $0.77/$4.18.


Natural Health Farm Holdings, Inc. (NHEL)

Stockopedia, Stockhouse, Market Exclusive, Capital Cube, 4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Last10k, and Barchart reported earlier on Natural Health Farm Holdings, Inc. (NHEL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natural Health Farm Holdings, Inc. is a biotechnology company working to establish a complete healthcare one-stop shop based on natural or naturopathic products. Since November of 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of various diseases and nutritional consulting services. Natural Health Farm Holdings is headquartered in Las Vegas, Nevada. The Company lists on the OTCQB.

Natural Health Farm provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. The Company’s principal activities are in retailing nutritional supplements, organic foods and health-care related products.

Via its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of numerous retail & franchise outlets throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.

Natural Health Farm Holdings announced this past January that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With the agreement, Natural Health Farm shall acquire 100 percent of Natural Tech R&D’s outstanding shares for USD 1 Million.

Natural Health Farm Holdings also announced in January that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements business in Malaysia.

Last month, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Health Naturopathic Academy Sdn Bhd (NHNA), a Malaysian healthcare education provider. Natural Health Naturopathic Academy offers courses on health, nutrition, dietetic and Chinese & natural medicine, which are accredited by over 30 countries.

Earlier this month, Natural Health Farm Holdings announced that it executed a term sheet to acquire a majority equity interest in Biodelta (Pty) Ltd. Biodelta is a contract developer and manufacturer of nutraceutical products in South Africa. Furthermore, this month, the Company announced that it executed an agreement to acquire all the issued and outstanding shares of Natural Health Farm, Inc. (NHF). NHF is a distributor of naturopathic and nutraceutical products in North Carolina and throughout the East Coast of the United States.

Natural Health Farm Holdings, Inc. (NHEL), closed Monday's trading session at $1.06, down 7.83%, on 703,305 volume with 195 trades. The average volume for the last 3 months is 240,671 and the stock's 52-week low/high is $0.649/$6.00.


Northern Superior Resources, Inc. (NSUPF)

Jet Life Penny Stocks, 24h Gold, Barchart, PennyStockHub, MarketWatch, Stockhouse, YCharts, OTC Markets, TraderPlanet, 4-Traders, Stock Press Daily, Stockwatch, Investing News Alerts, and Thehotpennystocks reported previously on Northern Superior Resources, Inc. (NSUPF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Northern Superior Resources, Inc. engages in the identification, acquisition, evaluation, and exploration of gold properties in the Provinces of Ontario and Quebec. The Company established as a diamond exploration business in 2002, under the name Superior Diamonds, Inc. In 2007, it transformed into a gold exploration company and renamed itself Northern Superior Resources, Inc. An exploration stage junior mining enterprise, Northern Superior Resources is headquartered in Sudbury, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

Currently, Northern Superior Resources is concentrating on exploring its Ti-pa-haa-kaa-ning (Northwestern Ontario) and 100 percent owned Croteau Est (Quebec) properties. The Company’s remaining properties (all 100 percent owned) in Quebec and Northwestern Ontario are available for option.

The Ti-pa-haa-kaa-ning (TPK- gold/silver/copper) property in northwestern Ontario is 30 x 20km. It contains two regional, strong and independent mineral systems. One is a gold-bearing shear system at least 24km long. The second is a newly discovered greenstone belt assaying as high as 727 g/t gold, 111 g/t silver and 4.05 percent copper.

The Croteau Est property is in one of Quebec’s more important and historic mining camps, Chapais- Chibougamau. The property measures approximately 30km east to west by 10-15km north to south. An inferred gold resource is defined on this property by Northern Superior Resources: 640,000 ounces of gold (with a cut off of 1.0 g/ t Au, totaling 11.6 million tonnes grading 1.7ppm gold). Furthermore, an additional exploration target, ranging from 3.2 to 3.8 million tonnes, for a total of 122,000 to 270,000 ounces of gold, was identified from mineralization, defined by single drill-hole intersections in the same deposit.

Last month, Northern Superior Resources unveiled its 2019 exploration plan for its 100 percent owned Lac Surprise property, Québec. The Company plans a two part exploration program. One part is a Ground or Unmanned Aerial Vehicle-Mounted (UAV) Magnetic Geophysics Survey ($200,000). The second part is a Core Drill Program ($800,000).

Additionally, last month, Northern Superior Resources announced that it started a 5,000 meter (m) core drill program on its Ti-Pa-Haa-Kaa-Ning (TPK) gold-silver-copper mineral property, Northwestern Ontario. The program will test six target areas to identify favorable alteration zones, structures and mineralization defining wider areas of potentially economic mineralization. The core drill program will comprise roughly 4,800m of drilling.

Northern Superior Resources, Inc. (NSUPF), closed Monday's trading session at $0.18, down 5.48%, on 1,800 volume with 3 trades. The average volume for the last 3 months is 1,770 and the stock's 52-week low/high is $0.0149/$0.221.


Atico Mining Corporation (ATCMF)

Junior Mining Network, OTC Markets, The Northern Miner, 4-Traders, Stockhouse, Marketwired, MarketWatch, InvestorsHub, Capital Cube, Streetwise Reports, Investing News, Barchart, and The Street reported previously on Atico Mining Corporation (ATCMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Atico Mining Corporation centers on exploring, developing, and mining copper and gold projects in Latin America. The Company focuses on developing and operating high margin midsized Cu-Au deposits. It has a proven team of mine developers and mine operators. Atico’s chief project is the El Roble mine in Colombia. Atico Mining is based in Vancouver, British Columbia and lists on the OTC Markets.

Atico is in production and producing cash flow at the El Roble mine. El Roble is in Carmen De Atrato, Colombia. El Roble is a 6,679-hectare project and is a producing mine with an 800 tonnes per day throughput capacity. The end product is CU (+AU, AG) concentrate. The deposit type is Mafic-Type Volcanic Massive Sulphide. Atico’s ownership of El Roble is 90 percent of the operating mine and surrounding claims.

Prior evaluations by Atico Mining identified high-grade mineralization below the lowest production levels at El Roble. These evaluations also defined a measured and indicated resource of 1.86 million tonnes grading 3.46 percent copper and 2.27 g/t gold.

On the larger land package, Atico has identified a prospective stratigraphic contact between volcanic rocks and black and grey pelagic sediments and cherts. This has been traced by Atico geologists for 10 kilometers. This contact has been determined to be an important control on VMS mineralization on which the Company has identified many target areas prospective for VMS type mineralization occurrence, which is the emphasis of the present surface drill program at El Roble.

This past January, Atico Mining announced operating results for the three and twelve month periods ended December 31, 2018 from its El Roble mine. Production totaled 5.81 million pounds of copper with 2,913 ounces of gold for Q4 2018 and 21.87 million pounds of copper with 11,344 ounces of gold in concentrates for the full year 2018.

Mr. Fernando E. Ganoza, Chief Executive Officer, said, “Atico has successfully concluded its fifth full year of operating the El Roble mine, exceeding most of the 2018 guidance while achieving the highest annual production results to date. In the upcoming year, we will continue aggressive exploration at the El Roble property with an intensified focus on the prospective 6,400-hectare land package while working towards achieving stated guidance.”

Atico Mining Corporation (ATCMF), closed Monday's trading session at $0.242, down 3.20%, on 8,200 volume with 6 trades. The average volume for the last 3 months is 24,180 and the stock's 52-week low/high is $0.168/$0.554.


NeuroOne Medical Technologies Corporation (NMTC)

The Stock Market Watch, YCharts, Stockopedia, Penny Stock Hub, OTC Markets, Street Insider, Trading View, Wallmine, Marketbeat, Business Insider, InvestorsHub, and 4-Traders reported earlier on NeuroOne Medical Technologies Corporation (NMTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NeuroOne Medical Technologies Corporation concentrates on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is changing the landscape of surgical care for neurological disorders through the development of high-definition, minimally invasive diagnostics and treatments. OTCQB-listed, NeuroOne Medical Technologies is based in Eden Prairie, Minnesota.

In 2017, the Company completed early feasibility testing for depth electrode and combination diagnostic/ablation depth electrode. In addition, it created its Physician Advisory Board. NeuroOne centers on the development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson’s Disease, Dystonia, Essential Tremors and other related brain related disorders.

The Company believes that technology in its pipeline can improve outcomes through reducing the risk of infection; decreasing inflammation of the brain during recording; and increasing accuracy and specificity of recorded brain activity. Furthermore, NeuroOne believes that technology in its pipeline can improve outcomes through minimizing invasiveness of the procedure; and reducing time-consuming, cumbersome, and expensive technical use and management within facilities. NeuroOne’s emphasis is on the development and commercialization of Diagnostic Recording and Therapeutic Modalities.

At present, the chief goals for NeuroOne Medical Technologies are to file patent application(s) based on the submitted 2017 provisional patents, and complete pre-clinical study for its diagnostic and diagnostic/ablation combination depth electrode. Moreover, main goals include ramping up production and continuing to strengthen its Physician Advisory Board where appropriate.

This past January, NeuroOne Medical Technologies announced the hiring of Mrs. Leah Noaeill as Senior Director of Marketing and Mr. Scott Heuler as Vice President of Sales to establish NeuroOne’s U.S. commercial organization and drive any future product launches. Mrs. Noaeill comes to the Company with 15 years in medical device marketing in a connected healthcare environment. Most recently, she worked at Smiths Medical leading the Infusion Software marketing and application support teams.

Mr. Heuler comes to NeuroOne Medical Technologies with more than 25 years in sales management, marketing and senior leadership positions in the medical device industry. Mr. Heuler’s background includes regional and senior sales positions with Boston Scientific Corporation in Interventional Cardiology, Structural Heart, Cardiac Rhythm Management and Peripheral Vascular. Before this, he held various senior sales and marketing roles with Guidant Corporation and U.S. Surgical Corporation.

NeuroOne Medical Technologies Corporation (NMTC), closed Monday's trading session at $4.99, down 0.20%, on 24,442 volume with 17 trades. The average volume for the last 3 months is 13,776 and the stock's 52-week low/high is $3.00/$10.00.


STEP Energy Services Ltd. (SNVVF)

Wallet Investor, MarketWatch, Street Insider, Seeking Alpha, GuruFocus, Marketbeat, Market Screener, and EN Digest reported on STEP Energy Services Ltd. (SNVVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

STEP Energy Services Ltd. is a technically focused, oilfield service company listed on the OTC Markets. It provides specialized coiled tubing and associated pumping and support equipment to service the deep horizontal well market in Western Canada, south Texas and Louisiana. STEP Energy Services has its head office in Calgary, Alberta.

At present, STEP Energy Services is the third largest pressure pumping company as measured by horsepower in Western Canada. The Company has added hydraulic fracturing services to its Canadian asset base.

Step applies fit-for-purpose coiled tubing, pumping, and hydraulic fracturing technology to boost reservoir performance in well stimulation and intervention projects for clients operating in unconventional oil, gas, and liquids rich plays. In addition, the Company provides STEP-PLEX diverting agents used as temporary blocking agents; chemical laboratory solutions; fluid pumping services for coiled tubing operations and standalone projects; and nitrogen pumping solutions.

Regarding Operational Efficiencies, the design of its purpose-built equipment is to improve operational efficiencies and productivity in extended reach wellbore designs. The design of the Company’s solutions are to maximize surface efficiencies while providing advanced downhole productivity.

STEP is a specialist in complex well stimulation and intervention programs. It provides collaborative services, customized solutions, as well as real-time data monitoring for challenging horizontal well bore operations. STEP is an industry leader and the pioneer of coiled tubing equipment, capable of servicing wells at extended reach depths, more efficiently and safer than ever before. The Company offers ultra-capacity coiled tubing spreads designed to reliably and efficiently service the ever more challenging intervention programs in the unconventional oil, gas, and liquids rich plays in North America.

The design of all of STEP’s coiled tubing units are for 44.5 mm to 73.0 mm (1-3/4" to 2-7/8”) OD tubing with lengths that service the extended reach challenges of horizontal wellbore. Injector specifications have been chosen to meet the demands of 24-hour continuous operations, and downhole pressures the Company’s clients are encountering.

Earlier this month, STEP Energy Services announced its financial and operating results for the three and twelve months ended December 31, 2018. The Company produced Q4 and full year Consolidated Revenue of $169.0 million and $781.8 million, respectively, versus $154.3 million and $533.2 million in the same periods of the year prior. The improvements were mainly attributable to the acquisition of all of the issued and outstanding stock of Tucker Energy Services Holdings, Inc., increased equipment deployed, and small increases in Revenue per Operating Day.

Net Loss for Q4 2018 was $58.5 million and totaled $39.3 million for the year ended December 31, 2018, versus Net Income of $17.5 million and $57.7 million, respectively, in the same periods of 2017. 2018 Net Loss was impacted by $46.0 million of impairment charges to goodwill associated with the U.S. fracturing cash generating unit.

STEP Energy Services Ltd. (SNVVF), closed Monday's trading session at $1.50, down 3.85%, on 8,250 volume with 3 trades. The average volume for the last 3 months is 565 and the stock's 52-week low/high is $1.3082/$6.249.


The American Energy Group, Ltd. (AEGG)

Penny Stock Tweets, Stockwatch, Dividend Investor, Real Investment Advice, InvestorsHub, Research Gate, Zacks, Stockhouse, 4-Traders, GuruFocus, The Street, MarketWatch, Wallet Investor, Marketbeat, Market Screener, and Business Wire reported beforehand on The American Energy Group, Ltd. (AEGG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

The American Energy Group, Ltd.  (AEGG)  is an energy resource royalty company listed on the OTC Markets. It is a non-operating oil and gas enterprise. The Company has an 18 percent  gross overriding royalty interest on the producing Yasin Block 2468-7 in South-Central Pakistan that comprises 172 acres. AEGG  has its corporate office  in Westport, Connecticut.

The Company’s strategy is to expand its portfolio of royalty and convertible Working Interests (WIs) in long-term petroleum leases. Additionally, its strategy is to create shareholder value through investing in exploration and early development projects with high cash-flow potential. AEGG’s focus will be high-impact South Asia energy development opportunities that are characterized by manifold target structures and locations with a potential for considerable hydrocarbon reserves.

AEGG’s other core assets comprise royalties and convertible carried WI’s in oil and gas leases. These include a  2.5 percent carried WI in Zamzama North Block No. 2667-8 under exploration  in South-Central, Sindh Province, Pakistan. Heritage Oil and Gas is the operator. This property consists of 557,951 square acres.

In addition, in the Zamzama North and Sanjawi Blocks, AEGG has the option to convert its 2.5 percent  carried WI’s at any time, on a well by well basis to a 1.5 percent  royalty, free of the costs of exploration  and development of the leases.  The convertible carried  WI  is "carried", which means  free of exploration and development costs,  as to the first  three wells for Zamzama North, and the first two wells for Sanjawi.
Furthermore, AEGG has a 2.5 percent carried WI in Sanjawi Block No. 3068-2 under exploration in North-Central, Baluchistan Province, Pakistan. Heritage Oil and Gas is the operator. This property is 302,895 square acres. The other joint venture (JV) partners are Hycarbex-American Energy, Inc, Sprint Energy, and Trakker Energy.

In May of 2018, AEGG announced that the Government of Pakistan granted to the Company's wholly-owned subsidiary, Hycarbex-American Energy an extension to the Yasin Exploration License relating back to the date of the request for extension in March of 2013. Company Management promptly started its plans for exploration and development activities on the Yasin Exploration License based on this extension. 

The American Energy Group, Ltd. (AEGG), closed Monday's trading session at $0.035, down 2.78%, on 14,983 volume with 2 trades. The average volume for the last 3 months is 14,315 and the stock's 52-week low/high is $0.025/$0.14.


Bluestone Resources, Inc. (BBSRF)

Stock Orange, Dividend Investor, Investors Hangout, OTC Markets, MarketWatch, 4-Traders, Geology for Investors, Current Charts, Wallmine, Barchart, OtcStockWatch, and Penny Stock Hub reported on Bluestone Resources, Inc. (BBSRF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bluestone Resources, Inc. concentrates on advancing its 100 percent owned Cerro Blanco Gold and Mita Geothermal Projects in Guatemala. The Cerro Blanco Project is a classic hot springs-related, low sulphidation gold-silver deposit. A mineral exploration and development company, Bluestone Resources has its head office in Vancouver, British Columbia.

The Cerro Blanco Project economics and updated mineral resource estimate for Cerro Blanco indicates a strong project with an expected nine-year mine life producing 952,000 ounces of gold and 3,141,000 ounces of silver. Initial capital expenditures estimated in the Preliminary Economic Assessment (PEA) to fund construction and commissioning is estimated at US$170.8 million with all in sustaining cash (AISC) estimated to be US$490 per ounce of gold produced.

The permitted Mita Geothermal Project is situated contiguous to Bluestone’s Cerro Blanco Gold Project in Guatemala. It is in southeast Guatemala, roughly 160 kilometers by road from the capital, Guatemala City. The Mita geothermal resource was discovered in the late 1990’s during gold exploration in southeastern Guatemala.

Bluestone Resources controls the required surface rights for the Mita Geothermal Project and the Cerro Blanco Project. The Cerro Blanco Gold Project is not dependent on the Mita Geothermal Project. However, Company Management’s belief is that there are potential synergies between the two that enhance the economics of the Cerro Blanco Gold Project beyond what was outlined in the PEA.

In July, Bluestone Resources announced further positive drill results from its resource definition drill program at the Cerro Blanco Gold project in Guatemala. Highlights include 9.6 g/t Au and 34.9 g/t Ag over 21.4 m (UGCB18-92); and 11.5 g/t Au and 48.6 g/t Ag over 12.9 m (UGCB18-96). Highlights also include 16.5 g/t Au and 18.4 g/t Ag over 7.9 m (CB18-393); and 7.0 g/t Au and 65.2 g/t Ag over 17.2 m (CB18-394) including 17.5 g/t Au and 197 g/t Ag over 4.1 m.

This week, Bluestone Resources announced a new high-grade mineral resource estimate for the Cerro Blanco Gold project in Guatemala. Highlights of the high-grade resource estimate (3.5 g/t Au cut-off) include Measured Resource totaling 96,184 ounces or 290,153 tonnes grading 10.31 g/t Au. Highlights also include Indicated Resource and grades in line with expectations - 1,105,284 ounces or 3,426,400 tonnes grading 10.03 g/t Au.

Furthermore, highlights include Inferred Resource of 357,319 ounces or 1,373,342 tonnes grading 8.09 g/t Au. This represents an increase of 308,000 from the PEA at the same cut-off.

Bluestone Resources, Inc. (BBSRF), closed Monday's trading session at $0.9134, up 0.37%, on 6,050 volume with 7 trades. The average volume for the last 3 months is 9,703 and the stock's 52-week low/high is $0.8064/$1.159.


Golden Matrix Group, Inc. (GMGI)

TipRanks, Stockflare, ClayTrader, Dividend Investor, Central Charts, Simply Wall St, YCharts, Infront Analytics, InvestorsHub, Stockhouse, Penny Stock Tweets, Wallet Investor, Morningstar, MarketWatch, Investor Place, Penny Stock Hub, Barchart, GuruFocus, Real Investment Advice, 4-Traders, last10k, and Capital Cube reported on Golden Matrix Group, Inc. (GMGI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Golden Matrix Group, Inc. is an established gaming technology company listed on the OTC Markets. It develops and owns online gaming IP. Additionally, the Company builds configurable and scalable white-label social gaming platforms for its global customers, located mainly in the Asia Pacific region.

Golden Matrix Group has its corporate office in Las Vegas, Nevada. The Company was previously known as Source Gold Corp. It changed its name to Golden Matrix Group, Inc. in March of 2016.

In strict compliance with current United States law, Golden Matrix’s sophisticated software automatically declines any gaming or redemption requests from within the U.S. The Company’s gaming IP includes tools for marketing, acquisition, retention and monetization of users. Its platform can be accessed via desktop and mobile applications.

In essence, Golden Matrix Group pioneers highly modular, configurable and scalable social gaming platforms for its worldwide customers. It does so in an effort to promote user acquisition, engagement, retention, as well as monetization.

Recently, Golden Matrix announced that it entered into a definitive distribution agreement with Red Label Technology LTD. to expand the number of gaming operators being serviced by Golden Matrix in the Asia Pacific region. Red Label Technology is an Asian-based company. It is owned and operated by a team of experienced social gaming entrepreneurs with wide-ranging distribution channels across Asia.

Red Label will be introducing its gaming operator clients/contacts to Golden Matrix’s New Generation GM-X System. This System is a state-of-the-art gaming platform. It incorporates an artificial intelligence (AI) component and a module that supports seamless integration with Sportsbooks and e-Sports.

In August, Golden Matrix Group announced that it launched and went live with its first four proprietary slot games. They are basic traditional Chinese Slot Games. Each game depicts one of the four seasons. They represent the first units of an exclusive Golden Matrix portfolio of games to be called GM Slots. Golden Matrix said it has an additional 18 games now under development and expected to go live over the next three months (as of August 7, 2018).

Golden Matrix Group, Inc. (GMGI), closed Monday's trading session at $0.0033, up 6.45%, on 3,240,550 volume with 36 trades. The average volume for the last 3 months is 7,003,990 and the stock's 52-week low/high is $0.00019/$0.0039.


TechPrecision Corp. (TPCS)

Energy and Capital, Wealth Daily, TopPennyStockMovers, Zacks, Stock Rich, FeedBlitz, SmallCapVoice, BullRally, HotOTC, CoolPennyStocks, PennyStockVille, MadPennyStocks, Marketbeat, StreetInsider, and Stock Market News Alert reported earlier on TechPrecision Corp. (TPCS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TechPrecision Corp., through its wholly-owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., is an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems. The Company’s objective is to be an end-to-end global service provider to its customers through furnishing customized and integrated turn-key solutions for completed products requiring custom fabrication and machining, assembly, inspection, and testing. OTCQB-listed, TechPrecision has its headquarters in Westminster, Massachusetts.

The Company’s products are used in the alternative energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others. TechPrecision has the fabrication capacity to see a client’s large-scale components through from initial processing to final finishing and assembly. This eliminates the requirement for outside servicing. In addition, it helps ensure lower costs.

TechPrecision’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Clean Technology, Energy, Medical, Aerospace, and Defense sectors. Ranor’s capabilities include Production Control; Engineering; Processing; Fabrication; Machining; Assembly & Finishing; Quality Assurance, and NDE & Inspection.

The design of the Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the growing worldwide demand for an experienced, knowledgeable machining and distribution center in Asia,  providing large-scale component fabrication solutions for the region's wind power and solar challenges. CMC utilizes one of the largest forges in the industry.

CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance.  CMC serves the Solar/LED; Wind; Nuclear; Clean Technology, Medical; and General Industrial industries.

Recently, TechPrecision reported financial results for Q1 ended June 30, 2018. Net Sales for Q1 were $4.1 million. This represents a 30 percent decrease versus Net sales of $5.8 million in the same quarter a year prior. The Q1 June 30, 2017 Net Sales were higher due to favorable timing with delivery schedules in that year ago period.

Mr. Alexander Shen, TechPrecision's Chief Executive Officer, said, ''Our results for the first quarter were impacted by lower gross margins, which were primarily the result of higher amounts of unabsorbed overhead related to a lower number of projects in production. By the end of the first quarter, however, we have started to return to target levels of project activity, primarily with certain projects that have longer build cycles.''

TechPrecision Corp. (TPCS), closed Monday's trading session at $0.98, up 2.08%, on 100 volume with 1 trade. The average volume for the last 3 months is 35,733 and the stock's 52-week low/high is $0.475/$1.07.


Artelo Biosciences, Inc. (ARTL)

Stockwatch, OTC Markets, Stockopedia, The Street, Dividend Investor, TradingView, Stockhouse, Wallmine, Simply Wall St, Market Screener, Real Investment Advice, Market Exclusive and Venture Line reported on Artelo Biosciences, Inc. (ARTL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Artelo Biosciences, Inc. is a biopharmaceutical company focused on the development of therapeutic treatments, which modulate the endocannabinoid system. The Company is advancing a portfolio of widely applicable product candidates. The design of these is to address significant unmet needs in numerous diseases and conditions, including cancer, pain, and inflammation. Artelo Biosciences is headquartered in La Jolla, California.

The endocannabinoid system (ECS) is a widespread neuromodulatory system. It plays a crucial role in human central nervous system development, synaptic plasticity, and the response to endogenous and environmental insults. Artelo Biosciences’ approach exploits manifold mechanisms to modulate the ECS. Candidate therapeutic compounds in the Company’s present portfolio are founded on targeting cannabinoid receptors and endocannabinoid transport inhibition utilizing synthetic cannabinoids and new chemical entity approaches.

The Company’s focus is on providing patient access to new therapies and applying proven biopharma thoroughness to its development programs. In addition, the Company is driving unique endocannabinoid system modulating therapeutics into new areas. Furthermore, it is partnering with world-class experts.

In April 2018, Artelo Biosciences and The Research Foundation For The State University of New York (RF/SUNY) announced that they entered into a license agreement.  With this agreement, Artelo obtains an exclusive global license to an intellectual property (IP) portfolio of Fatty Acid Binding Protein (FABP) inhibitor drug candidates that have multiple potential indications, including cancer, inflammation and pain.

During the first year of the agreement, Artelo Biosciences will collaborate with the Stony Brook University team that developed the technology to identify a lead development compound, develop a pharmaceutically acceptable formulation, and evaluate activity in nonclinical animal models across select indications. RF/SUNY is a not-for-profit organization and the largest comprehensive university-connected research foundation in America.

Recently, Artelo Biosciences announced that it entered into a worldwide research and development partnership with Syngene International Ltd., an India-based integrated discovery-development service provider, via its wholly-owned subsidiary, Trinity Research and Development Limited, and Aptus Clinical Ltd., a specialist UK-based Clinical Contract Research Organization (CRO) with specific expertise in oncology, rare diseases and advanced therapies. This partnership will concentrate on supporting the drug discovery and clinical development of ART27.13, Artelo Biosciences’ Phase 2 ready, high-potency dual cannabinoid agonist, in oncology.

Artelo Biosciences, Inc. (ARTL), closed Monday's trading session at $1.12, up 1.82%, on 100 volume with 1 trade. The average volume for the last 3 months is 772 and the stock's 52-week low/high is $0.27/$1.75.


Dajin Resources Corp. (DJIFF)

Investing News, Stockhouse, Streetwise Reports, Junior Mining Network, InvestorsHub, 4-Traders, GuruFocus, Epstein Research, StockInvest, Barchart, Wall St. Researcher, Wallet Investor, Equities, Marketwired, OTC Markets, TradingView, Investx, Dividend Investor, and MarketWatch reported on Dajin Resources Corp. (DJIFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dajin Resources Corp. is a lithium exploration company listed on the OTC Markets Group’s OTCQB. Via its interest in Dajin Resources S.A. (Dajin S.A.), the Company holds concessions or concession applications in Jujuy Province, Argentina. These were acquired in areas known to contain brines with Lithium, Potassium and Boron values. Dajin Resources has its corporate office in Vancouver, British Columbia.

The aforementioned land holdings exceed 93,000 hectares (230,000 acres). They are mainly located in the Salinas Grandes and Guayatayoc salt lake basins.  Dajin Resources projects include Teels Marsh, Alkali Lake, and Salinas Grandes.

The Teels Marsh Lithium Project in Nevada is 3,202 hectares - 7,914 acres. There are 403 placer claims. Teels Marsh is 100 percent owned by Dajin Resources (US) Corp., which is a wholly-owned subsidiary of Dajin Resources Corp. Construction of drill pads and roads is completed in expectation of starting a drill program later in 2018.

The Alkali Lake Lithium Project in Nevada is 2,262 hectares - 5,591 acres. There are 278 placer claims. Alkali Lake is 100 percent owned by Dajin Resources (US) Corp.

The Salinas Grandes Project in Argentina is 93,000 hectares - 230,000 acres. There are 25 concessions. Salinas Grandes is 100 percent owned by Dajin Resources S. A., which is a wholly-owned subsidiary of Dajin Resources Corp. This past February, Dajin announced the results of 25 shallow brine samples encompassing an area of 550 hectares (5.5 km2) in the northwestern corner of the 4,300-hectare (43 km2) San Jose and Navidad minas.  Concentrations ranged from 281 mg/l to 1,353 mg/l, averaging 591 mg/l Lithium.  A drill program for the San Jose and Navidad minas is now being organized.

Last week, Dajin Resources management reported that the Company’s engineers, Welsh Hagen Associates, Inc. (Reno, Nevada), completed the construction of access roads and drill pads at Dajin’s 100 percent owned, Teels Marsh Lithium brine project in Mineral County, Nevada. Welsh Hagen provided the design, prepared the BLM Notice of Intent and construction services for Dajin.  Tipton Trucking of Mina, Mineral County, Nevada, Coan Equipment and MB America both of Reno, Nevada supplied the construction equipment.

Dajin Resources Corp. (DJIFF), closed Monday's trading session at $0.042832, up 1.17%, on 55,000 volume with 12 trades. The average volume for the last 3 months is 68,790 and the stock's 52-week low/high is $0.0268/$0.10.


Relmada Therapeutics, Inc. (RLMD)

Dividend Opportunities, Investopedia,  ProfitableTrading, Wallstreetbuzz,  Investors Alley, The Observer, PCG Advisory, Streetwise Reports, Penny Stock Bets, StreetAuthority Financial, SmallCap Network, Trade of the Week, and WallstreetsHotteststocks reported on Relmada Therapeutics, Inc. (RLMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Relmada Therapeutics, Inc. is a clinical-stage, specialty pharmaceutical company.  It focuses on developing novel versions of proven drug products in combination with new chemical entities, which potentially address areas of high unmet medical need in the treatment of pain. The Company has a varied portfolio of lead products at different stages of development. It is developing novel therapies for the treatment of central nervous system (CNS) diseases. Relmada Therapeutics has its corporate office in New York, New York.

The Company’s lead products are d-Methadone (REL-1017), its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine - MepiGel (REL-1021), its orphan drug designated topical formulation of the local anaesthetic mepivacaine; oral buprenorphine - BuTab (REL-1028), its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol.

BuTab (REL-1028)  is its investigational, oral formulation of buprenorphine - an opioid that is widely used to treat addiction and chronic pain. The design of BuTab is to be delivered orally and reach safe and effective blood levels of buprenorphine by way of the gastrointestinal route of administration because of its modified release profile.

In April of 2017, Relmada Therapeutics announced that the Food and Drug Administration (FDA) granted Fast Track designation for d-Methadone (REL-1017 dextromethadone),  the Company’s novel N-methyl-D-aspartate (NMDA) receptor antagonist in development for the adjunctive treatment of major depressive disorder. 

Recently, Relmada Therapeutics announced that the European Patent Office issued a notice of allowance for patent application number 13773543.7 for "D-methadone for the treatment of psychiatric symptoms." This patent provides extensive coverage in Europe for d-Methadone (dextromethadone, REL-1017), a novel N-methyl-D-aspartate (NMDA) receptor antagonist, for the treatment of symptoms associated with a range of psychological and psychiatric disorders. These include depression, anxiety, fatigue, and mood instability.

In addition, Relmada Therapeutics recently announced that it acquired the worldwide rights to develop and market dextromethadone (REL-1017).

Mr. Sergio Traversa, Relmada Therapeutics’ Chief Executive Officer, said, "The clinically proven mechanism of action of dextromethadone shows potential benefits in the treatment of a wide range of CNS diseases and conditions, including rare diseases that represent significant areas of unmet need in healthcare. We believe that this new agreement is the most important transaction for Relmada since its inception, positioning us to target a wide range of development and global marketing opportunities for dextromethadone in the years ahead."

Relmada Therapeutics, Inc. (RLMD), closed Monday's trading session at $1.82, up 1.11%, on 5,972 volume with 10 trades. The average volume for the last 3 months is 19,941 and the stock's 52-week low/high is $0.671/$2.00.


QS Energy, Inc. (QSEP)

Equity Clock, Stockhouse, MarketWatch, RedChip, InvestorsHub, Stockopedia, Marketwired,, The Street, and Small Cap Exclusive reported earlier on QS Energy, Inc. (QSEP), and we report on the Company today, here at the QualityStocks Daily Newsletter.

QS Energy, Inc. is a developer of integrated technology solutions for the energy industry. It develops and commercializes energy efficiency technologies that help in meeting increasing global energy demands, improving the economics of oil extraction and transport, and lessening greenhouse gas emissions. QS Energy’s Intellectual Property  (IP)  portfolio includes 48 domestic and worldwide patents and patents pending. These have undergone development in combination with,  and exclusively licensed from, Temple University. OTCQB-listed,  QS Energy is headquartered in Tomball, Texas.

The Company’s  AOT™ (Applied Oil Technology) is a group of commercial crude oil pipeline flow assurance products designed to undergo installation at pipeline pump stations in the upstream, gathering, and midstream sectors. AOT™ is an integrated system. It improves critical operational efficiencies for pipeline operators globally.

AOT™ is an industrial hardware system. It is completely fabricated in the U.S.  AOT™ lowers the viscosity of unrefined oil utilizing low wattage electrical fields (electrorheology) to improve flow while in transit via pipelines.

AOT™ technology delivers performance that can be measured in each of the areas of importance in the movement hydrocarbon stream - from reservoir to the point of sale. QS Energy’s  AOT™  stand-alone or supplemental pipeline solutions increase flow rates;   reduce  power consumption; optimize flow assurance; enhance pipeline integrity; and prevent bottlenecks.

QS Energy has its new strategic plan. The core mission of this plan is to hasten market adoption of its AOT™ technology. The Company is  now positioned to complete its development from research and development (R&D) to commercialization. All through last year, it worked to improve the efficacy and efficiency of its AOT technology, executing a retrofit program underpinned by lessons learned while operating its equipment on midstream pipelines under commercial operating conditions.

Recently, QS Energy has been working diligently on the installation and operation of one or more pilot projects. The Company’s efforts to secure one or more pilot projects are now centered on specific prospects in three primary markets. These are the United States South America, and Asia. Each of these prospects operates heavy crude oil pipelines with an identified system-wide need likely to benefit AOT viscosity reduction.

QS Energy, Inc. (QSEP), closed Monday's trading session at $0.286, down 1.04%, on 204,582 volume with 43 trades. The average volume for the last 3 months is 141,763 and the stock's 52-week low/high is $0.061/$0.379.


The QualityStocks Company Corner

Global Consortium, Inc. (OTC: GCGX)

The QualityStocks Daily Newsletter would like to spotlight Global Consortium, Inc. (OTC: GCGX).

Global Consortium, Inc. (OTC: GCGX) is a diversified cannabis holding company that recently acquired several companies in the cannabis space. Headquartered in Florida, Global Consortium is expanding its reach nationwide with several subsidiaries, partnerships and licensing agreements. Golden Consortium reported over $600,000 in sales in the quarter ended September 30, 2018, and over $2 million in CBD product sales for 2018.

Among Global Consortium’s assets are the following:

  • Infused Edibles has been selling a wide selection of specialty, CBD-infused edible products including gummies, baked goods, fruit and nut mixtures, savory and spicy dried fruits and jerky, and cannabidiol oils for over 13 years. Infused Edibles has received 17 first place awards for its dedicated line of U.S. grown, CBD isolate-infused food products. Infused Edibles operates out of a 6,000 square foot building, servicing 400 stores with dedicated sales reps and eight distributors in 15 states.
  • Infused Oils is a northern California company that produces a premium, 100 percent solvent and pesticide-free cannabis distillate that delivers potency, purity and flavor to medical cannabis patients. Infused Oils uses state-of-the-art CO2 supercritical extraction methods to preserve the delicate cannabinoid and full spectrum terpene profiles of its medical grade oil. Produced from uncommon, boutique cannabis strains that are micro-grown and hand trimmed, Infused Oils creates natural, medicinal cannabis extracts that are strain specific THC and CBD oils of premium quality.
  • America’s first Cannabis Mall, under construction in the Sacramento, California, area, is designed to house cannabis manufacturing, distribution, delivery, retail, testing and cultivation – all under one 64,000 square foot building that showcases various cannabis operations from seed to shelf. The Cannabis Mall will house the largest manufacturing facility of THC and CBD distillates and edibles believed to be operational in the United States. The testing lab at the Cannabis Mall will service outside cannabis vendors as well as all products manufactured there. The distribution space will be leased to a 3rd party with a 50 percent revenue share for Global, while all of Global’s products will be distributed free.

Global Consortium recently entered into a Letter of Intent with MJ Munchies, Inc., a subsidiary of Nightfood Holdings, Inc. (OTC: NGTF), for an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked(TM) mark owned by MJ Munchies. The LOI includes provisions for monthly royalty payments, sales and growth thresholds, and a distribution of proceeds if, and when, the Half-Baked brand is ever sold to a third party.

Global Consortium has also received a weekly order, worth a minimum of $50,000 per week, from the only licensed delivery company servicing the Lake Tahoe, Nevada, area. Over 30 million people live in and visit the Lake Tahoe area, which has no recreational dispensaries. As part of the deal, all of Global’s product lines – Infused Edibles, Indulge Oils and any other products produced – will be offered by the delivery company.


Director, CEO and President Matthew Dwyer has been working in the securities industry since 1986 when he began his career working for Donaldson, Lufkin, and Jenrette. Dwyer went on to hold several securities licenses until 1991 when he ventured off on his own. He has worked in all sectors of the industry from owning an Investors Relations company with one of the first call rooms to working on reverse mergers and debt financing. Dwyer has a well-versed working knowledge of the securities industry, working with both OTC and SEC reporting companies.

Director and incoming President Manuel Losada has over 30 years of healthcare industry experience dedicated to building and achieving profitability and growth. His extensive background includes medical/surgical and device manufacturers, distribution and supply chain, group purchasing organizations, pharmaceuticals and medical product delivery systems. Losada holds a proven track record of successful mergers and acquisitions, business development, and long-range planning for Fortune 500 and multinational companies. He is an energetic professional with exceptional analytical, organizational and people skills, strong personal ethics and integrity. Dwyer is a highly organized team-builder with strong leadership experience and excellent communication skills.

Andrew Moll, Independent Director, has worked as a sales rep for approximately 25 years calling on all types of stores including specialty, resorts, sporting goods, casinos, major department stores and mass merchants. Moll worked in private label production overseas and domestic for NASCAR, Wal-Mart, Coca Cola, Six Flags, Disney, Universal Studios, Sea World, and Hard Rock. In addition, he spent 10 years working with U.S. retailers and apparel brands to secure overseas production with factories in Central and South America as well as China, India, and Pakistan. Moll spent the last 8 years as vice president of sales for a resort athleisure company.

Tom Roland, Chief Operating Officer, is the founder of Indulge Oils. Roland has built a strong reputation in the business over the past 5 years for producing a superior product and delivering on time. He will operate the Cannabis Mall and all manufacturing for both the edibles and distillates departments. Roland is a proven entrepreneur experienced in building profitable companies and has a passion for entrepreneurship, developing innovative approaches to industry challenges, and building vibrant company cultures. He accelerates development and deployment of solutions while maintaining profitable growth. Roland also serves as an advisor to several start-up ventures and continues to empower teams though his provocative leadership.

Marc Adesso, Securities Counsel, of Waller Lansden Dortch & Davis, LLP, is recognized for his work on securities regulation and corporate governance. He has established a national practice counseling issuers, conducting mini-IPOs under Regulation A+ of the JOBS Act, which currently allows companies to raise up to $50 million per year from the general public. Adesso is a key member of the firm’s blockchain and cryptocurrency practice and is lauded as one of the world’s top attorneys in the area of registered offerings of cryptocurrencies such as ICOs. In recognition of his national reputation in the space, as well as being Tennessee’s only veteran cannabis attorney, Adesso chairs the firm’s legalized cannabis practice which counsels clients on the rapidly changing landscape facing the cannabis industry.

Global Consortium, Inc. (OTC: GCGX), closed the day's trading session at $0.02836, up 3.13%, on 1,766,752 volume with 98 trades. The average volume for the last 3 months is 3,162,606 and the stock's 52-week low/high is $0.016/$0.1083.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software Inc. (OTC: PFSF), an emerging business development technology innovator, is closing in on the launch date of BOAPIN, the company’s proprietary e-commerce platform designed to improve product traceability and deliver much-needed cross-border trade solutions to global subscribers. Pacific Software anticipates that its new blockchain-based trade platform will be able to register new buyers and sellers within the first quarter of 2019, according to a news release (

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, up 175.00%, on 100 volume with 1 trade. The average volume for the last 3 months is 40 and the stock's 52-week low/high is $2.00/$5.50.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that sales of its certified-organic cannabis have started with national distribution to medical patients. To view the full press release, visit:

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.65, up 2.24%, on 1,285,543 volume with 1,857 trades. The average volume for the last 3 months is 1,386,851 and the stock's 52-week low/high is $1.607/$7.894.

Recent News


TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or "the Company") recently signed definitive documents to purchase for US$15 million a 196,000 sq ft vertically integrated facility in northern California as announced on March 20, 2018. Included in the purchase is a total of 5.567 acres of land and institutional grade packaging and extraction equipment. The Company retained the services of an independent third-party business valuation firm (the "Firm") to determine the enterprise value of the proposed business to be conducted by the Company on the property. The Firm concluded with a valuation range of US$50 million - $75 million using two different valuation methods to reach their conclusion.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $3.85, up 13.24%, on 207,271 volume with 172 trades. The average stock's 52-week low/high is $0.769/$3.85.

Recent News


Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.84, up 2.72%, on 40,957 volume with 128 trades. The average volume for the last 3 months is 46,956 and the stock's 52-week low/high is $0.949/$19.45.

Recent News


Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Kontrol Energy Corp. (CSE: KNR, OTCQB: KNRLF, FSE: 1K8) (the "Company" or "Kontrol") and Toyota Tsusho Canada Inc. 'TTCI' are pleased to announce they have signed an agreement to implement Smart Factory technology solutions combining Kontrol's Internet of Things (IoT) hardware and software solutions with TTCI's existing production, operating improvement platforms, and power generation / HVAC products for the North American automobile and parts OEMs.

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.79, up 11.27%, on 423,559 volume with 179 trades. The average volume for the last 3 months is 26,484 and the stock's 52-week low/high is $0.46/$0.99.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom Holdings Inc. (Choom™) (CSE: CHOO) (OTCQB: CHOOF) ("Choom"), an emerging adult and medical use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce, following its strategy to become a multi-state operator, that it intends to expand into Florida.  Choom, through its wholly owned US subsidiary, Choom Holdings USA Inc., has signed a letter of intent ("LOI") to purchase a 95% equity interest in a Florida-based vertically-integrated cannabis applicant (the "FL Company"). Also today, the company was highlighted in an article looking at how, across the U.S. and Canada, the consumer demand for cannabis products continues its steady growth… but one obstacle could be the unmet need for more dispensaries.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.53, up 1.44%, on 1,782,071 volume with 667 trades. The average volume for the last 3 months is 521,579 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX), an established financial news and investment portal, and a leading industrial hemp retailer for the Chinese-speaking community, recently announced that it will add a high-end, luxury brand of full spectrum CBD oil to its product offerings. Also today, the company was highlighted in an article looking at how, across the U.S. and Canada, the consumer demand for cannabis products continues its steady growth… but one obstacle could be the unmet need for more dispensaries.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.48, up 2.13%, on 29,542 volume with 40 trades. The average volume for the last 3 months is 85,663 and the stock's 52-week low/high is $0.365/$1.25.

Recent News


Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Dynamic plant-based food and beverage company Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced receipt of a Health Canada cultivation license for Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its portfolio company, Spot Therapeutics Inc., for its Fredericton-based production and distribution facility. To view the full press release, visit:

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.325, off by 1.48%, on 307,620 volume with 593 trades. The average volume for the last 3 months is 643,288 and the stock's 52-week low/high is $2.40/$11.82.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is expanding its full-spectrum cannabidiol (CBD) product distribution in wider markets as a new study by Cowen & Co. sees cannabis products reaching $16 billion in the U.S. by 2025 ( ETST’s larger market includes pharmacies, dispensaries, health care practitioners, athletic clubs, clinics and chiropractors throughout the United States (

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.64, off by 8.57%, on 24,193 volume with 24 trades. The average volume for the last 3 months is 31,181 and the stock's 52-week low/high is $0.421/$2.45.

Recent News


Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) announces the availability of a CannabisNewsAudio Publication titled, “CBD Industry Soars in Wake of Farm Bill; Massive Growth Projected to Continue.” To hear the CannabisNewsAudio version, visit: To read the full editorial, visit: Also today, CannabisNewsWire released a report on the company detailing how WLDFF is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.525, off by 0.46%, on 51,732 volume with 30 trades. The average volume for the last 3 months is 13,297 and the stock's 52-week low/high is $0.009/$1.139.

Recent News


BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce that it has closed the first tranche (“First Tranche”) of its previously-announced (March 20, 2019) non-brokered private placement of up to 20,000,000 common shares of the Company at a price of C$0.10 per common share for gross proceeds of up to approximately C$2,000,000 (the “Offering”).  A total of 7,500,000 common shares at a price of C$0.10 per common share have been issued under the First Tranche for gross proceeds of C$750,000. The Company paid a total of C$15,000 cash finder's fees on subscriptions under the First Tranche.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0831, off by 4.37%, on 54,192 volume with 9 trades. The average volume for the last 3 months is 21,818 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Hydroponic supplier Sugarmade Inc. (OTCQB: SGMD) has been making swift moves to deal with this demand, acquiring other supply companies and outlets.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.05433, off by 4.68%, on 711,185 volume with 96 trades. The average volume for the last 3 months is 1,378,953 and the stock's 52-week low/high is $0.0425/$0.259.

Recent News


Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (

Countries around the world, most notably China (, have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database ( This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements ( Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?


Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.04945, up 7.50%, on 27,000 volume with 9 trades. The average volume for the last 3 months is 45,409 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.